Showing 661-670 of 4005 results for "".
On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
https://reachmd.com/programs/project-oncology/io-therapies-for-patients-with-her2-negative-ggejc/35513/For patients who are diagnosed with metastatic gastric cancer, the five-year overall survival rate is roughly seven percent, underscoring the need for additional treatment options.1 Fortunately, there has been advancement in gastric cancer care, including the FDA approval of tislelizumab plus platinClinical Neuroinflammatory Mimics of Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/clinical-neuroinflammatory-mimics-of-multiple-sclerosis/54599/NMOSD, MOGAD, and MS have overlapping clinical presentations but are distinct inflammatory CNS diseases, each with their own established diagnostic criteria.Efgartigimod Shows Early Promise for Primary Sjögren’s Disease
https://reachmd.com/programs/living-rheum/efgartigimod-shows-early-promise-for-primary-sjogrens-disease/36333/Safety and Efficacy of Onasemnogene Abeparvovec in Pediatric SMA Across Expanded Weight Cohorts
https://reachmd.com/programs/neurofrontiers/safety-and-efficacy-of-onasemnogene-abeparvovec-in-pediatric-sma-across-expanded-weight-cohorts/36614/Evidence Builds for Cell-Based Influenza Vaccines
https://reachmd.com/programs/medical-industry-feature/evidence-cell-based-influenza-vaccines/36269/Randomized controlled trials have shown data supporting the safety and efficacy of cell-based influenza vaccines in adults and children.1-4 However, effectiveness studies have historically relied on outcomes based on clinical diagnosis of influenza-like illness rather than test-confirmed influenza.5Looking Back, Striving Forward: Novel Directions from Dr. Mark DeFrancesco, ACOG's 66th President
https://reachmd.com/programs/advances-in-womens-health/looking-back-striving-forward-novel-directions-dr-mark-defrancesco-acogs-66th-president/7487/Dr. Matt Birnholz welcomes Dr. Mark DeFrancesco, 66th President of The American College of Obstetricians and Gynecologists, to the program. Dr. DeFrancesco looks back at the accomplishments of his immediate predecessors, and reflects on the three-fold initiative to which he will dedicate his effortsA National Consensus Is Forming on Perinatal Quality
https://reachmd.com/programs/clinicians-roundtable/a-national-consensus-is-forming-on-perinatal-quality/3993/There is a national consensus on standards for perinatal care, but what does that mean and how did these come about? Maureen Corry, executive director of the ChildBirth Connection tells host Bruce Japsen of the Chicago Tribune about coming changes in perinatal standards at hospitals and how these meRating Physicians: Google's Foray Into the Controversy
https://reachmd.com/programs/clinicians-roundtable/rating-physicians-googles-foray-into-the-controversy/3143/Host Dr. Bruce Bloom welsomes Dr. Roni Zeiger, product manager of Google Health and primary care physician, to discuss the controversial realm of physician ratings and how Google will enter this arena.The Impact of Heparin Contamination Going Forward
https://reachmd.com/programs/clinicians-roundtable/the-impact-of-heparin-contamination-going-forward/2884/The FDA has issued an extensive recall on several contaminated heparin products, problems which have been traced back to ingredients from China, which were so similar to heparin that the contaminants fooled standard quality testing. Dr. Jawed Fareed, professor of pathology and pharmacology at LoyolaTopical Cell-Free Therapy for Psoriasis: A Sponge-Based Secretome Formulation
https://reachmd.com/programs/clinicians-roundtable/topical-cell-free-therapy-for-psoriasis-a-sponge-based-secretome-formulation/36363/